Tag: Acthar

Biotech, Industry, Pricing, Regulations

Federal prosecutors make another claim against Mallinckrodt over Acthar prices

March 4, 2020

Via: Biopharma Dive

Acthar was first approved in 1952 for the treatment of rheumatoid arthritis, but its acquisition by Questcor from the former Aventis in 2001 allowed the new owner to test out a strategy of label expansions and steep price rises. In […]